Nonsmall cell lung cancer in stage IA: Mortality patterns after surgery;Carcinoma broncogénico no anaplásico de células pequeñas en estadio IA. Cirugía y patrones de mortalidad

Archivos de Bronconeumologia

Volumn 41, Issue 4, 2005, Pages 180-184

  Padilla, J ^a   Penalver J C ^a   Jorda C ^a   Calvo, V ^a   Escriva J ^a   Ceron J ^a   Garcia Zarza A ^a   Pastor, J ^a   Blasco, E ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Bronchogenic carcinoma; Lymph node excision; Mortality; Stage IA; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHUS CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; EXCISION; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; POSTOPERATIVE PERIOD; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURVIVAL RATE;

EID: 17844411172     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13073166     Document Type: Article

References (34)

1. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, et al. Incidence of local recurrence and second primary tumor in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109:120-9.
2. Inoue K, Sato M, Fujimura S, Sakurada A, Takahashi S, Usuda K, et al. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg. 1998;116:407-11.
3. Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg. 2001;71:1759-64.
4. Battafarano RJ, Piccirillo JF, Meyers BF, Hsu H-S, Guthrie TJ, Cooper JD, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123:280-7.
5. Iizasa T, Suzuki M, Yusufuku K, Iyoda A, Otsuji M, Yoshida S, et al. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma. Ann Thorac Surg. 2004;77:1896-903.
6. Rice D, Kim HV, Sabichi A, Lippman S, Lee JJ, Williams B, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003;76:1001-8.
7. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Shimosato Y, Naruke T. Lymph node involvement, recurrence, and prognosis in resected small, peripheral, non-small-cell lung carcinomas: are these carcinomas candidates for video-assisted lobectomy? J Thorac Cardiovasc Surg. 1996;111:1125-34.
8. Sugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg. 1998;22:290-4.
9. Oda M, Watanabe Y, Shimizu J, Murakami S, Ohta Y, Sekido N, et al. Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: the role of systematic nodal dissection. Lung Cancer. 1998;22:23-30.
10. Koike T, Terahima M, Takizawa T, Kurita Y, Yokoyama A. Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg. 1998;115:1015-20.
11. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg. 1999;19:17-24.
12. Wu Y-C, Jeff Lin C-F, Hsu W-H, Huang B-S, Huang M-H, Wang L-S. Long-term results of pathological stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control. Eur J Cardiothorac Surg. 2003;24:994-1001.
13. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029-34.
14. Grupo de Trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol. 1998;34:437-52.
15. Martini N, Melamed MR. Multiple primary lung cancer. J Thorac Cardiovasc Surg. 1975;70:606-11.
16. Marcus P, Bergstralh E, Fagerstrom R, Williams D, Fontana R, Taylor W, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92:1308-16.
17. Bollen EC, Van Duin CJ, Theunissen PH, Vt Hof-Grootenboer BE, Blijham GH. Mediastinal lymph node dissection in resected lung cancer: morbidity and accuracy of staging. Ann Thorac Surg. 1993;55:961-6.
18. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Espanola de Neumología y Cirugía Torácica (GCCB-S). Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol. 2001;37:495-503.
19. Keller SM. Complete mediastinal lymph node dissection - does it make a difference? Lung Cancer. 2002;36:7-8.
20. Keller SM, Adak S, Wagner H, Johnson DH, Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stage II and IIIa non-small cell lung cancer. Ann Thorac Surg. 2000;70:358-65.
21. Izbicki JR, Passlick B, Karg O, Bloechle C, Pantel K, Knoefel WT, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg. 1995; 59:209-14.
22. Ginsberg R, Cox J, Green M, Bulzebruck H, Grunewald D, Harper P, et al. Consensus report: Staging Classification Committee. Lung Cancer. 1997;17:11S-3S.
23. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). Clinical tumour size and prognosis in lung cancer. Eur Respir J. 1999; 14:812-6.
24. Takizawa T, Terashima M, Koike T, Akamatsu H, Kurita Y, Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:248-52.
25. Graham AN, Chan KJ, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117:246-51.
26. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978;76:832-9.
27. Okada M, Tsubota N, Yoshimura M, Miyamoto Y. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. J Thorac Cardiovasc Surg. 1998;116:949-53.
28. Asamura H, Nakayama H, Kondo H, Tsuchiya R, Naruke T. Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. J Thorac Cardiovasc Surg. 1999;117:1102-11.
29. Yano T, Hara N, Ichinose Y, Asoh H, Yokohama H, Otha M, et al. Local recurrence after complete resection for non-small-cell cancer of the lung. Significance of local control by radiation treatment. J Thorac Cardiovasc Surg. 1994;107:8-12.
30. Izbicki JR, Passlick B, Pantel K, Pichlmeier U, Hosch SB, Karg O, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer. Ann Surg. 1998;227:138-44.
31. Wu Y, Huang Z, Wang S, Yang X, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 2002;36:1-6.
32. Funatsu T, Matsubara Y, Ikeda S, Hatakenaka R, Hanawa T, Ishida H. Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg. 1994;1994:321-8.
33. Sigurdson ER. Lymph node dissection: is it diagnostic or therapeutic? J Clin Oncol. 2003;21:965-7.
34. American College of Surgeons Oncology Group. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with NO or N1 (less than hilar) non-small cell lung carcinoma. Disponible en: http://www.acosog.org